Moreover, Biohaven’s Phase 3 trial of taldefgrobep alfa in SMA is expected to gain attention following positive results from a ... therapies to improve the lives of patients with debilitating ...
REGENXBIO is advancing a pipeline of AAV Therapeutics for rare and retinal diseases, including RGX-202 for the treatment of Duchenne ... including Novartis' Zolgensma ® for children with spinal ...
Please note that on today's call, we will be making forward-looking statements, including statements concerning the potential of TSHA-102, including the reproducibility and durability of any favorable ...
Margao: Families caring for children with chronic illnesses and neurological disorders require a respite centre in Goa where they can temporarily leav.